TrianglePUBLICATIONS · 38701390
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Aug 10
- First author
- Pasquini MC
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pasquini MC
- type
- Author
- name
- Wallace PK
- type
- Author
- name
- Logan B
- type
- Author
- name
- Kaur M
- type
- Author
- name
- Tario JD
- type
- Author
- name
- Howard A
- type
- Author
- name
- Zhang Y
- type
- Author
- name
- Brunstein C
- type
- Author
- name
- Efebera Y
- type
- Author
- name
- Geller N
- type
- Author
- name
- Giralt S
- type
- Author
- name
- Hari P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pasquini MC
- type
- Author
- name
- Wallace PK
- type
- Author
- name
- Logan B
- type
- Author
- name
- Kaur M
- type
- Author
- name
- Tario JD
- type
- Author
- name
- Howard A
- type
- Author
- name
- Zhang Y
- type
- Author
- name
- Brunstein C
- type
- Author
- name
- Efebera Y
- type
- Author
- name
- Geller N
- type
- Author
- name
- Giralt S
- type
- Author
- name
- Hari P
- type
- Author
- bibliography ids
- nci-bib-252a283748a16200699a4004
- book metadata
- content sha256
- 523ee1f252023a09d0d66dda95424e5e34eda6eab90a543562ae372c30bff588
- document type
- citation
- dois
- 10.1200/JCO.23.00934
- electronic publication date
- display
- 2024 May 3
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38701390
- immutable id
- pubmed:38701390@523ee1f252023a09d0d66dda95424e5e34eda6eab90a543562ae372c30bff588
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 23
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2757-2768
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38701390
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 1c9d6877ebe7ffdc7430dc29bce9a032eea6186a7a04a7b929adc3a5904da0db
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Aug 10
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Randomized Controlled Trial
- Multicenter Study
- Research Support, Non-U.S. Gov't
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.
Preserved source evidence · Not medical advice